Skip to main content
. 2022 Feb 14;14(2):382. doi: 10.3390/v14020382

Table 3.

Survival rate and tumor incidence at 56 days post-infection.

rMDV Survival Rate Tumor Incidence
vRB-1B_S-Meq 90.9% (10/11) 18.2% (2/11)
vRB-1B_Meq 41.7% (5/12) 58.3% (7/12)
vRB-1B_L-Meq 0% (11/11) 100% (11/11)